Delivery Order SPE2DB22D3301-SPE2DB26FX4EN
Award Date 10/31/25
Potential Completion Date 11/24/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $97,728.21 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) on September 19, 2025, with an ultimate completion date of October 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $51,681.12 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete procurement action issued under...
- The Defense Logistics Agency awarded a delivery order valued at $155,043.24 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (quantity: 28 units) on September 29, 2025, with an ultimate completion date of October 21, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor...
- The Defense Logistics Agency has awarded a delivery order valued at $48,095.44 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count packages). This firm fixed-price, competitively awarded delivery order is scheduled for completion by October 20, 2025, with the product being delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $53,251.31 for Revlimid 15 mg capsules (100-count units) on August 28, 2025, with an ultimate completion date of September 19, 2025. The contract employs firm fixed price pricing and carries no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Revlimid 10 mg capsules (28-count package) with a ceiling value of $102,180.00. This firm fixed-price delivery order, which is expected to be completed by September 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Revlimid 10 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $52,575.49 and an ultimate completion date of September 26, 2025. This is a competitively awarded, non-set-aside delivery order issued to support federal medical procurement needs. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 8, 2025, for the supply of Revlimid 5 mg capsules (28-count) with a ceiling value of $12,329.15. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 30, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at approximately $51.7K to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units). This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive procurement executed under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $160,992.02 delivery order to AmerisourceBergen Drug Corp for 28-count packages of Revlimid 10 mg capsules, with an ultimate completion date of October 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing for the supply of this specialized pharmaceutical product. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...